Nickel Sensitivity

NCT ID: NCT04058743

Last Updated: 2025-01-09

Basic Information

• Recruitment Status: TERMINATED
• Clinical Phase: NA
• Total Enrollment: 8 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2019-09-27
• Study Completion Date: 2024-12-21

Brief Summary

The purpose of this study is to compare clinical outcomes of patients with self reported nickel sensitivity undergoing primary total knee arthroplasty (TKA) with conventional, standard-of-care vs nickel-free implants. The hypothesis is that patients with a self-reported nickel sensitivity will have similar patient reported outcome scores compared to those patients without reported nickel sensitivity. Therefor the anticipation is for there to be no differences in other clinical outcome measures or functional outcome scores between the two cohorts.

Detailed Description

Metal implants are a mainstay of orthopedic treatment, and a variety of metal implants have been utilized for more than 40 years. Total knee replacement implants have been comprised of a variety of metal, ceramic, and plastic components. Current standard-of-care for TKA employs a cobalt chrome alloy femoral implant that articulates with the polyethylene surface of the tibial component. This cobalt chrome alloy can contain up to 1% nickel.

While most patients report pain relief and satisfaction after TKA, there are a number of complications that can result. Infection, component loosening, polyethylene wear, and malalignment are common reasons for persistent pain after TKA. Metal sensitivity as a cause of persistent pain after total joint arthroplasty is a controversial topic. Cutaneous metal hypersensitivity has a prevalence of approximately 10-15% in the general population, with nickel being the most common metal sensitizer with a prevalence near 14%. Cross reactivity with cobalt chrome and nickel is very common.

The role of metal allergy in orthopedic surgery and total joint arthroplasty is a poorly understood relationship. The cause and effect relationship of this process has not been delineated - it is unclear if the immunogenic response causes implant failure, or implant failure releases hapten particles with lead to a deep tissue reaction.

Metal hypersensitivity after TKA is a rarely documented phenomenon without specific diagnostic criteria, and there is much debate on if this is even a true diagnosis. The two most commonly described presentations include 1) dermatitis or 2) persistent painful synovitis although these have only been described in case reports without defined diagnostic criteria. Few reports exist regarding the diagnosis and management of these conditions. There is no reliable or generally accepted test to predict allergy to total joint replacement components. Patient history of metal sensitivity is not a reliable indicator of TJA outcome, as 25% of patients with well-functioning TJA implants have a reported metal allergy. A nickel or metal sensitivity has not been statistically identified as a risk factor for any specific cutaneous or deep tissue reaction, complication, or poor outcome after TKA.

Typically, metal sensitivity patients are identified after having a superficial skin reaction after dermal contact with a metal. Nickel containing jewelry is a common precipitator. The true diagnosis of skin sensitivity to metal is diagnosed by cutaneous patch testing, often employed by dermatologists. This test is not specific or sensitive for the diagnosis of deep tissue metal sensitivity. In a case control study, Granchi et al followed 94 patients without metal implants, with stable painless TKA, and with TKA and evidence of loosening. The study found no predictive value in dermal patch testing for metal hypersensitivity and the stability of TKA implants. Verma et al followed 30 patients with dermatitis following TKA. Fifteen were available for patch testing, but only seven patients tested 1+ or 2+ reaction to a metal. Dermatitis in all patients cleared with topical steroid. The relationship between positive patch testing and clinically relevant deep tissue reactions has not been delineated.

Lymphocyte transformation testing (LTT) or lymphocyte stimulation testing involves obtaining patient lymphocytes from a peripheral blood draw, and testing reactivity with a variety of antigens, including cobalt, nickel, and zirconium. Many argue that this test better replicates the sensitization that occurs in deep tissue after TJA, but its correlation to outcomes after arthroplasty has never been shown. Niki et al preformed lymphocyte stimulating testing on 92 patients (108 knees) undergoing primary TKA. 24 patients tested positive for metal hypersensitivity. Ultimately only five went on to develop dermatitis. Thus the clinical significance of positive results of lymphocyte stimulation testing is still unknown.

Additionally, serum metal levels are often elevated in patients with well-functioning TKA, and thus this test is not recommended for diagnosis of metal sensitivity. As a result, other causes such as infection, malalignment, aseptic loosening, referred pain, or systemic pain syndromes should all evaluated in persistently painful TKA.

At this time, metal sensitivity is not considered a significant cause of TKA failure. As the literature is inconclusive on identification and management of patients with metal hypersensitivity there is currently no indication for metal allergy screening prior to TKA. No study has found that patients with a previously known metal sensitivity have an increase rate of failure or revision TKA compared to those without. None of the major academic orthopedic societies recommend routine use of nickel free implants. There is currently no data showing correlation between nickel allergy and poor outcomes after total joint replacement with nickel containing implants. While non-nickel containing TKA implants have been developed, there is no evidence-based criteria for their use in specific patient populations. The goal of this study is to compare Knee Society Scores in patients with self-reported metal allergy who receive standard of care nickel containing implants vs oxidized zirconium nickel free implants for primary TKA.

Conditions

Knee Arthropathy; Allergic Reaction

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: PREVENTION
• Blinding Strategy: SINGLE

Study Groups

TKA with standard cobalt chromium components

Patients randomized to this group will receive the standard cobalt chromium components in their total knee arthroplasty

Group Type: ACTIVE_COMPARATOR

TKA with standard cobalt chromium components

Intervention Type: DEVICE

Patients will be randomized to receive either the standard cobalt chromium components or nickel free components

TKA with nickel free components

Patients randomized to this group will receive nickel free components in their total knee arthroplasty

Group Type: EXPERIMENTAL

TKA with nickel free components

Intervention Type: DEVICE

Patients will be randomized to receive either the standard cobalt chromium components or nickel free components

Interventions

TKA with nickel free components

Patients will be randomized to receive either the standard cobalt chromium components or nickel free components

Intervention Type: DEVICE

TKA with standard cobalt chromium components

Patients will be randomized to receive either the standard cobalt chromium components or nickel free components

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

• Patients undergoing primary TKA for the diagnosis of osteoarthritis or inflammatory arthritis with self-reported nickel allergy. Patients are routinely asked about nickel sensitivity as a part of the standard pre operative questionnaire already in place.

Exclusion Criteria

• Patients less than 18 years of age
• Patients undergoing revision TKA
• Non english speaking patients
• Patient who have medical comorbidities that prevent elective TKA

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Rush University Medical Center

OTHER

Sponsor Role: lead

Responsible Party

Craig J Della Valle, MD

Professor of Orthopaedic Surgery

Responsibility Role: PRINCIPAL_INVESTIGATOR

Locations

Rush University medical Center

Chicago, Illinois, United States

Countries

United States

Other Identifiers

18112703

Identifier Type: -

Identifier Source: org_study_id